NL
DE
The main purpose of SUNRISE-CRC is to determine whether treatment with a high dose of sunitinib provides a better chance of survival and slows the progression of (colo)rectal cancer (CRC) more than standard treatment with TAS-102. Sunitinib, at a low daily dose, has been approved as a treatment for kidney cancer, but not yet for colorectal and rectal cancer. The standard treatment for metastatic colorectal or rectal cancer in this line is TAS-102, a form of chemotherapy. This study also examines whether certain proteins or other characteristics can be detected in the patient's blood and tumor that are predictive of the effect of the treatment. The biomaterial and associated clinical data are being collected and stored in the SUNRISE-CRC biobank.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
First implications of the Radboud Biobank new business model
15 July 2025It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.
go to page
Relocation of Radboud Biobank samples to Central Freezing Facility
15 July 2025The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.
go to page
Standardized Radboud Biobank procedures for sample handling in Elabgids
15 July 2025The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.
go to page
Temporary new location Radboud Biobank Office
15 July 2025The Radboud Biobank office has moved to a temporary new location: route 832 - M325.04.255 (building F).
go to page
Europe Biobank Week 2025
15 July 2025The Europe Biobank Week 2025 was a great success for the Dutch biobank community with a strong presence of Dutch biobanking and biomedical research.
go to page
National Biobanks & Collections Dag 2025
6 May 2025The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.
go to page